This HTML5 document contains 222 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n12http://dx.doi.org/10.1186/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q90751316
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel наукова стаття, опублікована 16 жовтня 2019 article scientifique publié en 2019 artículu científicu espublizáu n'ochobre de 2019 scientific article published on 16 October 2019
p:P577
wds:Q90751316-8B899153-0E7C-4F6B-9A4E-C730802007BF
wdt:P577
2019-10-16T00:00:00Z
p:P2860
wds:Q90751316-071610C5-43CF-4BE1-BF2F-48B2CF2AEFE7 wds:Q90751316-0922853F-2EA4-40AA-AEBF-7C0664488851 wds:Q90751316-F0EB9342-0FA7-496B-8725-ED1A6DCC1C6D wds:Q90751316-F40DBA72-0209-4671-A6E9-549EA9AC271A wds:Q90751316-F4681364-F806-4977-8B5B-CA7A71FB918B wds:Q90751316-F4CC149A-042B-442C-B79A-A8CF780B800D wds:Q90751316-F5120FF4-3DDE-43B0-BB42-C8DBD30B8E05 wds:Q90751316-F7172BFB-EB6D-47A0-B92A-FCCE13C9B29C wds:Q90751316-FB0F88E9-3063-460D-8BDF-276773DE7A36 wds:Q90751316-DBF72E4D-D5A5-48AE-A1C0-F46825B57FBB wds:Q90751316-DC0931C8-5932-4293-931A-ADA90E47DE9A wds:Q90751316-E76033A6-455B-4B23-89AF-8717E9189810 wds:Q90751316-E8737585-EC0E-4D75-B74C-E2FB3E2CF0FF wds:Q90751316-EC2819EA-65B0-400A-ACA7-E1A98B2E431E wds:Q90751316-ED19F38B-742B-4D0B-A3BB-E822CB940BBA wds:Q90751316-EE756A25-C43D-4B35-8801-CB69F86C86D4 wds:Q90751316-CD3636C4-E846-4095-9C44-329DBD0DC750 wds:Q90751316-CE12C3DE-0C82-4C84-B9DC-BDF4ABB43378 wds:Q90751316-CEFE42B9-D17A-4016-863A-2C2D326C8F77 wds:Q90751316-D65777D3-9C3D-4315-8989-93D12C25EDF3 wds:Q90751316-D87EEB61-771C-4FA2-9DBD-3C34A6476FF6 wds:Q90751316-D9D419F3-7658-4E67-8672-E7A00886E140 wds:Q90751316-BA8CAAAA-A87A-4D0F-B524-20A0EB204867 wds:Q90751316-BB145728-E0D8-45EC-8B79-796239973462 wds:Q90751316-C0739DEA-E073-40FF-AD87-9F36C6E29E68 wds:Q90751316-C519F4EC-A992-4DC6-8403-AA8FE4C111A3 wds:Q90751316-C7F582C0-2A5E-4A8A-BE6D-8DCBE6E8BA26 wds:Q90751316-CC0BC1E8-D50D-4BEB-A7A2-870B6D86188D wds:Q90751316-A39D79B5-2AC0-4FFD-9EB8-1E7359232E9A wds:Q90751316-A51A2AC5-3E77-425E-96B9-E7964B459056 wds:Q90751316-A6060EC2-E9CB-4DF3-A8C9-2D87EFB6B09F wds:Q90751316-A6C78019-A2DA-4F49-BC70-BA2239818935 wds:Q90751316-B184A91C-D093-4DF8-9A2E-8D1FF30FF7CE wds:Q90751316-B2E44F17-AAD3-4B1A-A3B9-A8B32A89B6D5 wds:Q90751316-95DAEA89-7AFB-4BA3-BD4B-5B52672D475A wds:Q90751316-97B56090-0A4C-47A1-B1BB-D0F534D087A7 wds:Q90751316-9AEB594A-D44C-49CB-B534-FC35574F4BEC wds:Q90751316-9B262121-FE6F-4013-8589-80E77C07BFED wds:Q90751316-9C180D77-2E46-443F-B79A-EDE34F0E94BC wds:Q90751316-9C4256E3-B09E-41C4-8451-18B1BBC141C3 wds:Q90751316-889C9654-3F04-450C-B974-1FD80D63E140 wds:Q90751316-88B12CC7-D84D-4989-89F7-FC06B731DD7C wds:Q90751316-8CD41CBD-9772-4FAF-B385-B3AA078DFC6C wds:Q90751316-9050EFA2-4223-4FB4-9CA7-CD3891ED77B5 wds:Q90751316-90584CC9-8003-41B0-B7D8-860927DC4FA1 wds:Q90751316-925DF0AE-288A-4E2E-BEFE-B35C6A1785E7 wds:Q90751316-949909E6-BE9B-4701-913F-2ABA067D14E4 wds:Q90751316-6BCE4F4E-6EA8-40E1-9FB6-8EAF2A92220B wds:Q90751316-7140428E-669D-47E2-AF33-5F789A1E2B1E wds:Q90751316-74089E07-CDDF-4C32-83B9-72D05214CF81 wds:Q90751316-7E794463-7152-4B8D-993A-146579963122 wds:Q90751316-7EC31C44-15B4-453E-9FF7-67B9A7D52050 wds:Q90751316-8695393C-41BA-4F0A-AF1F-EAA4E2635988 wds:Q90751316-5612ABCF-D0AB-4BC5-B384-FA70DBF0DC3F wds:Q90751316-5A19006B-F0AD-471D-BC27-8020DD1235A3 wds:Q90751316-5DD8A1F6-6F5A-4CD5-B553-BD1C4F11F404 wds:Q90751316-61F7E7BA-993D-4973-8EDC-51D84FD4BA34 wds:Q90751316-63743CC9-BC50-4F2C-B602-D033EF1CD312 wds:Q90751316-69728183-A6F9-4518-9E32-347E4E27F704 wds:Q90751316-6AD8BD0A-0285-47CE-92EB-0A0E82F36DD1 wds:Q90751316-4B32FD8E-021D-458C-A8D5-C4BCC5358B67 wds:Q90751316-4E3F7E8D-E942-4F14-B462-7A11CD375780 wds:Q90751316-52E9D59D-4F8D-46E1-B6D2-00F82899742D wds:Q90751316-53C3B035-1AD4-451A-9F21-140D68188540 wds:Q90751316-5446012D-FF20-4647-BE04-DB4F9149D7C0 wds:Q90751316-30FE5032-C982-439A-998D-423A16B82B13 wds:Q90751316-357143DB-1CC0-472E-915E-4FFAA6F3D75C wds:Q90751316-35C22E55-344A-4394-8A6F-8E8236C9C3B4 wds:Q90751316-39A496AF-5EA3-4856-A755-BECE8BE2767E wds:Q90751316-3D3F57B7-C3BF-4A16-BB30-5B21F857C486 wds:Q90751316-3D69C749-6FF0-4D5D-80BE-224714038DD5 wds:Q90751316-3F869E81-D55D-406F-B395-143FC6858523 wds:Q90751316-12595938-0801-4FDD-98D8-AF661EF0AFBA wds:Q90751316-16180192-3E51-4D43-A89E-B49404E614CB wds:Q90751316-1937187C-993F-49AD-90A4-C7287C559BC1 wds:Q90751316-1D762F16-7E3F-4F04-99A0-E02D605E03D7 wds:Q90751316-2A4473FE-8ADE-4E9A-BBDA-D04D86109806 wds:Q90751316-2D9876A3-1975-4DD6-8A8E-D9AE056A04C2 wds:Q90751316-01F777F2-D84C-4C0A-8786-8388BC8FC384 wds:Q90751316-0343EA23-E8EE-42AB-8F7D-1D5E73B15301 wds:Q90751316-03B18459-BD82-4070-95D3-6129E86E7502
wdt:P2860
wd:Q36885857 wd:Q39462903 wd:Q45071563 wd:Q41460307 wd:Q46442782 wd:Q33669457 wd:Q47358369 wd:Q35822654 wd:Q38203186 wd:Q34321928 wd:Q40794876 wd:Q40610317 wd:Q37077832 wd:Q40499461 wd:Q90702187 wd:Q45378484 wd:Q30990540 wd:Q53654042 wd:Q47131115 wd:Q35907055 wd:Q67920425 wd:Q71353748 wd:Q57051876 wd:Q36948373 wd:Q51615057 wd:Q34622865 wd:Q35730542 wd:Q36900877 wd:Q50890438 wd:Q42870892 wd:Q35174840 wd:Q41189816 wd:Q64100749 wd:Q74284393 wd:Q37348914 wd:Q41044367 wd:Q60609612 wd:Q28263732 wd:Q26998392 wd:Q50920212 wd:Q58796906 wd:Q34492429 wd:Q36538145 wd:Q41756471 wd:Q34470974 wd:Q33683285 wd:Q55131841 wd:Q55155589 wd:Q43080891 wd:Q34444495 wd:Q43523371 wd:Q39753591 wd:Q39795273 wd:Q38005307 wd:Q38630163 wd:Q38280407 wd:Q35819278 wd:Q37401956 wd:Q39527311 wd:Q37195528 wd:Q90290692 wd:Q72591855 wd:Q38018403 wd:Q38690230 wd:Q37846915 wd:Q69886442 wd:Q40205808 wd:Q36640747 wd:Q43905778 wd:Q81288780 wd:Q37962416 wd:Q34529799 wd:Q34529883 wd:Q83153385 wd:Q34659323 wd:Q90430447 wd:Q83428166 wd:Q45101630 wd:Q33778129 wd:Q35713624 wd:Q67473419
p:P2093
wds:Q90751316-D71CDEB6-9266-426B-AC5B-47CE385D60E0 wds:Q90751316-CD9E9288-F1C8-47D6-AFB3-3B5198A27040 wds:Q90751316-C27E2C48-8CA6-44E9-B00F-1C716DB63114 wds:Q90751316-FDFF33D9-E36E-414D-9807-76808B26EE65 wds:Q90751316-E33D7D35-0DC4-4B1A-96B8-E4347069DE18 wds:Q90751316-02AA224D-785C-46D9-8F13-19EDE70B32F5 wds:Q90751316-2AA9DD90-A80F-48EC-B5B2-E6E9F8FDAFF7 wds:Q90751316-53A8E846-8768-4B9C-8F02-7CC3FB06DF78 wds:Q90751316-41588695-610A-4362-B24E-9BC03EAB8CA5 wds:Q90751316-45578CC3-9D7E-44A4-A3DF-6E44A13CDBF8
wdt:P2093
Antonio Giuliani Enrico Ricevuto Gemma Bruera Pierluigi Cosenza Oncology Network ASL1 Abruzzo Alessandro Chiominto Mario Schietroma Stefania Mastropietro Alessandra Di Sibio Francesco Carlei
rdfs:label
Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimen: an Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimen: an
skos:prefLabel
Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimen: an Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimen: an
schema:name
Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimen: an Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimen: an
p:P50
wds:Q90751316-9D9A65B9-4CD7-4BB0-8AD6-F93473CE645C
wdt:P50
wd:Q59663409
p:P1476
wds:Q90751316-FF159113-34E2-41CB-8E34-3C23E416A5BA
wdt:P1476
Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimen: an experience of multidisciplinary management in clinical practice
p:P304
wds:Q90751316-B6245ABB-C746-456F-882F-31CC2D5A9A12
wdt:P304
960
p:P31
wds:Q90751316-6D24DA09-9497-4325-8983-EC8C9ED5A73D wds:Q90751316-7f2267bd-33b7-470a-82e7-0f55277a0bf9
wdt:P31
wd:Q13442814 wd:Q2782326
p:P921
wds:Q90751316-AB601294-3177-4727-8E42-30748EBD50A8
wdt:P921
wd:Q413299
p:P698
wds:Q90751316-08777923-E20D-4294-8823-B3CD50F11F41
wdtn:P698
n9:31619203
wdt:P698
31619203
p:P1433
wds:Q90751316-3E5AA55B-4247-4117-B9CE-A1E91442B4F8
wdt:P1433
wd:Q326300
p:P433
wds:Q90751316-9D614E77-F713-4F42-A128-C93FE889ECBB
p:P478
wds:Q90751316-0DE498DA-94BD-4914-8DB8-9A49FB0FA305
wdt:P433
1
wdt:P478
19
p:P356
wds:Q90751316-AD4DF681-6EC2-4A4B-93DE-CA576760F251
wdtn:P356
n12:S12885-019-6214-Z
wdt:P356
10.1186/S12885-019-6214-Z
p:P932
wds:Q90751316-5ACCA576-84C7-40CE-A18D-2BF8DD7FE4CC
wdt:P932
6796336